序号 |
标题 |
次数 |
作者 |
发布时间 |
84871 |
3-[(2,4-二硝基苯基)亚甲基腙]-6-(3,5-二甲基吡唑)-S-四嗪(DMHT) |
98 |
WYQ |
2024-11-27 |
84872 |
3-[(对硝基苯基)亚甲基腙]-6-(3,5-二甲基吡唑)-S-四嗪(DPHX) |
93 |
WYQ |
2024-11-27 |
84873 |
DOTA-Biotin-Sarcosine,DOTA-生物素-肌氨酸 |
98 |
zcy |
2024-11-27 |
84874 |
双金属螯合物Gd&Bi-PDOTA-G2 |
97 |
kx |
2024-11-27 |
84875 |
四嗪探针F-Tz4是一种用于化学和生物学研究的探针分子 |
127 |
WYQ |
2024-11-27 |
84876 |
meso-酯基BODIPY-四嗪光动力探针 |
134 |
WYQ |
2024-11-27 |
84877 |
四嗪-氟硼荧(dipyrromethene boron difluoride,简称BODIPY) |
290 |
WYQ |
2024-11-27 |
84878 |
Bromoacetamido-PEG5-DOTA,CAS号:2353410-19-0 |
91 |
zcy |
2024-11-27 |
84879 |
1293368-74-7,DOTA标记的多肽 |
88 |
zyl |
2024-11-27 |
84880 |
3,6-双胍基-1,2,4,5-四嗪三硝基均苯三酚盐 |
94 |
WYQ |
2024-11-27 |
84881 |
DOTA-Z(PDGFRβ)-tri探针 ,螯合剂DOTA修饰PDGFRβ三聚亲和体ZPDGFRβ-tri |
98 |
kx |
2024-11-27 |
84882 |
3,6-双胍基-1,2,4,5-四嗪三硝基间苯二酚盐 |
91 |
WYQ |
2024-11-27 |
84883 |
3,6-双胍基-1,2,4,5-四嗪三硝基苯酚盐(DGTZ-TNP盐) |
112 |
WYQ |
2024-11-27 |
84884 |
6-氨基胍基-1,2,4,5-四嗪-3-酮(AGTzO) |
99 |
WYQ |
2024-11-27 |
84885 |
DOTA-NAPamide trifluoroacetate;935886-72-9 |
83 |
zcy |
2024-11-27 |
84886 |
5,7-二硝基苯并1,2,3,4-四嗪-1,3-二氧化物(DNBTDO) |
112 |
WYQ |
2024-11-27 |
84887 |
DOTA-Palm-3PRGD2, DOTA-Palm修饰3PRGD2药物 |
108 |
kx |
2024-11-27 |
84888 |
7-硝基苯并1,2,3,4-四嗪-1,3-二氧化物(7-NBTDO) |
104 |
WYQ |
2024-11-27 |
84889 |
DOTA-FAPI-04 ,DOTA偶联成纤维细胞活化蛋白抑制剂 |
216 |
kx |
2024-11-27 |
84890 |
446061-19-4 DOTA-p-NH2-Bn-(COOt-Bu)4 DOTA-P-苯-氨基-四叔丁酯 |
104 |
zcy |
2024-11-27 |
84891 |
5-硝基苯并1,2,3,4-四嗪-1,3-二氧化物(5-NBTDO) |
111 |
WYQ |
2024-11-27 |
84892 |
DOTA octreotide,大环配体奥曲肽 |
103 |
zyl |
2024-11-27 |
84893 |
3,6-二胍基-1,2,4,5-四嗪(DGTZ) |
106 |
WYQ |
2024-11-27 |
84894 |
gallium Ga 68-DOTATATE , 镓68偶联DOTATATE螯合物 |
177 |
kx |
2024-11-27 |
84895 |
3,6-二叠氮基-1,2,4,5-四嗪(DIAT) |
105 |
WYQ |
2024-11-27 |
84896 |
DOTA N-hydroxysulfosuccinimide ester 170908-81-3 DOTA-活性酯 |
95 |
zcy |
2024-11-27 |
84897 |
四嗪类高氮含能化合物 |
218 |
WYQ |
2024-11-27 |
84898 |
p-SCN-Bn-DOTA , 2-[(4-异硫氰基苯基)甲基]-1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸 |
94 |
kx |
2024-11-27 |
84899 |
咪唑并四嗪(Imidazopyrazine) |
98 |
WYQ |
2024-11-27 |
84900 |
二聚体多肽,250612-06-7 |
107 |
zyl |
2024-11-27 |
84901 |
DOTA-(t-Butyl)3-PEG5-azide 点击化学试剂 |
107 |
zcy |
2024-11-27 |
84902 |
降冰片烯衍生物(C16-NCA) |
188 |
WYQ |
2024-11-27 |
84903 |
DOTA-CS微球 ,壳聚糖微球上接枝螯合剂1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸(DOTA) |
86 |
kx |
2024-11-27 |
84904 |
1, 4, 7,10-四氮杂环十二烷-1, 4, 7-三(乙酸)-10-(2-硫乙基)乙酰胺 |
88 |
zcy |
2024-11-27 |
84905 |
3,6-二肼基-1,2,4,5-四嗪(DHT) |
126 |
WYQ |
2024-11-27 |
84906 |
DBCO-SS-PEG-DOTA 二苯并环辛炔-聚乙二醇之四氮杂环十二烷 |
91 |
zyl |
2024-11-27 |
84907 |
3-叠氮基-6-(3,5-二甲基吡唑)-1,2,4,5-四嗪(IADMPT) |
107 |
WYQ |
2024-11-27 |
84908 |
3-肼基-6-(3,5-二甲基吡唑)-1,2,4,5-四嗪(HDMP |
115 |
WYQ |
2024-11-27 |
84909 |
p-NH2-Bn-DOTA(B-200);181065-46-3;基于NOTADOTA定制和偶联 |
82 |
zcy |
2024-11-27 |
84910 |
DOTA-CSar-1 ,DOTA-胆酰肌氨酸 |
144 |
kx |
2024-11-27 |
84911 |
DOTA-MeTz,1610950-41-8,DOTA-甲基四嗪 |
96 |
zyl |
2024-11-27 |
84912 |
四嗪Tetrazine (C18-Tz) |
264 |
WYQ |
2024-11-27 |
84913 |
3-硝铵基-6-(1H-四唑-5-基)-[1,2,4]三唑[4,3-b][1,2,4,5]四嗪羟胺盐(TATTN·NH3OH) |
126 |
WYQ |
2024-11-27 |
84914 |
3-硝铵基-6-(1H-四唑-5-基)-[1,2,4]三唑[4,3-b][1,2,4,5]四嗪铵盐(TATTN·NH4) |
110 |
WYQ |
2024-11-27 |
84915 |
HA-ASP-CYS-Gd-DOTA ,透明质酸为载体的靶向肿瘤的大分子T1钆基造影剂 |
127 |
kx |
2024-11-27 |